清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Targeting the NRF2/HO-1 Antioxidant Pathway with Consequences for Notch Signaling in FLT3-ITD Positive AML: A Novel Therapeutic Approach

癌症研究 髓系白血病 Notch信号通路 生物 酪氨酸激酶 下调和上调 受体酪氨酸激酶 信号转导 化学 药理学 细胞生物学 生物化学 基因
作者
Marisa Hornbaker,Mary E. Irwin,LaNisha L. Patterson,Shelley M. Herbrich,Patrick A. Zweidler‐McKay,Joya Chandra
出处
期刊:Blood [Elsevier BV]
卷期号:126 (23): 2470-2470 被引量:1
标识
DOI:10.1182/blood.v126.23.2470.2470
摘要

Abstract Approximately 30% of patients with acute myeloid leukemia (AML) harbor activating mutations in the fms-like tyrosine kinase receptor 3 (FLT3). Such mutations are associated with increased propensity to relapse and dramatically decreased survival. FLT3 tyrosine kinase inhibitors (TKI), such as quizartinib, have shown modest clinical effects as single agents, and resistance remains a significant clinical problem. In addition to constitutive activity of the FLT3 receptor, AML cells with an internal tandem duplication of FLT3 (FLT3-ITD) exhibit elevated levels of reactive oxygen species (ROS). Antioxidants such as heme-oxygenase 1 (HO-1) are often upregulated in conjunction with increased ROS levels. In addition to its role as an antioxidant, HO-1 also has known proliferative and anti-apoptotic functions in some cell types. A study in non-small cell lung carcinoma recently suggested that HO-1 inhibits the Notch pathway through binding the Notch receptor. As Notch signaling exerts pro-apoptotic effects in AML, targeting HO-1 may induce Notch signaling, representing a potential therapeutic approach. Our data show that HO-1 is particularly elevated in FLT3-ITD expressing AML cells. Interestingly, HO-1 protein was found to be further elevated in AML cells with acquired resistance to FLT3-directed TKI compared to TKI-sensitive cells. Importantly, knockdown of HO-1, or inhibition of HO-1 catalytic activity with zinc protoporphyrin (ZnPP), leads to decreased survival and proliferation, demonstrating a critical pro-survival role of HO-1. We have determined that expression of HO-1 is under the control of NRF2, a transcriptional regulator of the antioxidant response, in FLT3-ITD positive AML cells. Inhibition of NRF2 with brusatol resulted in increased sensitivity to quizartinib in TKI-sensitive cell lines. Further, brusatol restored sensitivity to low nanomolar concentrations of quizartinib in TKI-resistant cells. Together, our work shows that combined inhibition of FLT3 and NRF2 using quizartinib and brusatol, respectively, exhibits synergy in the context of FLT3-ITD AML. Given the reported interaction between HO-1 and Notch, we sought to determine whether this interaction occurs in AML. Using the TCGA AML database, we found significant co-occurrence of HMOX1 (HO-1) and NOTCH2 mRNA expression in 200 patient samples. In vitro immunoprecipitation of the Notch2 receptor revealed that HO-1 directly interacts with Notch2 in FLT3-ITD positive AML cells. Importantly, brusatol treatment resulted in activation of the Notch pathway as demonstrated by cleavage of the Notch receptor and increased transcript levels of HES1, a canonical downstream target of Notch signaling. Given that HO-1 interacts with Notch2 and is under NRF2 control, we propose that decreasing HO-1 levels with brusatol treatment will modulate the Notch pathway such that its anti-leukemic effects can be exerted. In conclusion, inhibition of HO-1, directly or through NRF2 inhibition, demonstrates synergistic effects with FLT3 inhibition in both TKI-sensitive and -resistant AML. Furthermore, NRF2 inhibition induces Notch activation, providing a potential mechanism for this synergistic combination. Our data suggest that antioxidant modulation is a potential therapeutic approach for FLT3-ITD positive AML. Disclosures No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
紫熊发布了新的文献求助10
1秒前
自然如曼完成签到 ,获得积分10
2秒前
3秒前
小巧惜蕊完成签到,获得积分10
4秒前
故意的绿真完成签到,获得积分10
13秒前
拼搏的小凝完成签到,获得积分10
24秒前
30秒前
紫熊发布了新的文献求助10
36秒前
仁爱的鹤轩完成签到,获得积分10
38秒前
53秒前
1分钟前
紫熊发布了新的文献求助10
1分钟前
英勇问晴完成签到,获得积分10
1分钟前
自然的妙梦完成签到,获得积分10
1分钟前
伶俐小懒猪完成签到,获得积分10
1分钟前
1分钟前
孝顺的怜寒完成签到,获得积分10
1分钟前
2797924221完成签到,获得积分10
1分钟前
1分钟前
Autin完成签到,获得积分0
1分钟前
1分钟前
tuimao发布了新的文献求助10
1分钟前
keyan完成签到,获得积分10
2分钟前
zx586440的应助被科研通管家采纳,获得20
2分钟前
清脆晓瑶完成签到,获得积分10
2分钟前
缓慢不正完成签到,获得积分10
2分钟前
2分钟前
木头鱼完成签到,获得积分10
2分钟前
淡定的板栗完成签到,获得积分10
2分钟前
悲伤的小袁完成签到,获得积分10
2分钟前
2分钟前
2分钟前
淡然的紫伊完成签到,获得积分10
2分钟前
迷人的晓灵完成签到,获得积分10
2分钟前
3分钟前
shoemaker完成签到,获得积分10
3分钟前
6666发布了新的文献求助10
3分钟前
Lemenchichi完成签到,获得积分10
3分钟前
害羞的又菡完成签到,获得积分10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780496
捐赠科研通 7767299
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476688